The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Fresenius Medical Care AG & Co KGaA

NYSE: FMS
Last

(U.S.) $44.13

Today's change-0.03 -0.07%
Updated September 27 4:02 PM EDT. Delayed by at least 15 minutes.
 

Fresenius Medical Care AG & Co KGaA

NYSE: FMS
Last

(U.S.) $44.13

Today's change-0.03 -0.07%
Updated September 27 4:02 PM EDT. Delayed by at least 15 minutes.

Fresenius Medical Care AG & Co KGaA down slightly

Fresenius Medical Care AG & Co KGaA closed down just (U.S.)$0.03 Tuesday to (U.S.)$44.13. Over the last five days, shares are unchanged, but have gained 5.47% over the last year to date. This security has performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $43.67
  • Previous close(U.S.) $44.16
  • High(U.S.) $44.13
  • Low(U.S.) $43.62
  • Bid / Ask(U.S.) $40.11 / (U.S.) $0.00
  • YTD % change+5.47%
  • Volume109,660
  • Average volume (10-day)118,094
  • Average volume (1-month)172,985
  • Average volume (3-month)168,269
  • 52-week range(U.S.) $38.11 to (U.S.) $47.52
  • Beta0.57
  • Trailing P/E24.47×
  • P/E 1 year forward21.93×
  • Forward PEG2.28×
  • Indicated annual dividend(U.S.) $0.45
  • Dividend yield1.02%
  • Trailing EPS(U.S.) $1.80
Updated September 27 4:02 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.42%Sector:Industry:

Latest Company News

  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue4,4204,2054,3484,231
Total other revenue--------
Total revenue4,4204,2054,3484,231
Gross profit1,3991,3181,4681,382
Total cost of revenue3,0222,8882,8792,850
Total operating expense3,7793,6653,6863,618
Selling / general / administrative729785788770
Research & development39374035
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income641540662614
Interest income (expense), net non-operating-120-116-125-106
Gain (loss) on sale of assets--------
Other--------
Income before tax539435574514
Income after tax370297393346
Income tax, total168138180168
Net income294228317262
Total adjustments to net income--------
Net income before extra. items294228317262
Minority interest-76-69-77-83
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items294228317262
Inc. avail. to common incl. extra. items294228317262
Diluted net income294228317262
Dilution adjustment00----
Diluted weighted average shares306306304305
Diluted EPS excluding extraordinary itemsvalue per share0.960.751.040.86
Dividends per sharevalue per share0.800.000.000.00
Diluted normalized EPSvalue per share0.960.751.040.86